This inventor holds 3 USPTO granted patents and 7 published patent applications. Top assignees: Warner-Lambert Company, Other. Active years: 1995-2001.
Company Filing History:
Years Active: 1995-2001
Title: Leonard Post: Innovator in Retroviral Research
Introduction
Leonard Post is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of retroviral research, particularly in developing methods to combat retroviral infections, including those caused by HIV. With a total of 3 patents, his work has the potential to impact the treatment of AIDS and improve patient outcomes.
Latest Patents
Leonard Post's latest patents focus on the use of a transdominant negative retroviral integrase. One of his key inventions is a method for using a transdominant negative integrase gene to make cells resistant to retroviral infections, including those resulting from HIV. This patent outlines a method for introducing the integrase gene into mammalian cells, as well as the vectors and methods for constructing these cells. Additionally, he has developed a method for treating AIDS by administering an effective amount of the integrase gene, either alone or in combination with other agents useful for gene therapy, antiviral agents, or interleukin-2. His pharmaceutical delivery methods also incorporate the integrase gene, enhancing the potential for effective treatment strategies.
Career Highlights
Throughout his career, Leonard Post has worked with various organizations, including the Warner-Lambert Company. His experience in the pharmaceutical industry has equipped him with the knowledge and skills necessary to innovate in the field of retroviral research.
Collaborations
Leonard has collaborated with notable individuals such as Annette Lynn Meyer and Tod Paul Holler. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Leonard Post's innovative work in retroviral research and his patents demonstrate his commitment to improving treatments for retroviral infections. His contributions have the potential to make a significant impact in the medical field, particularly in the fight against HIV and AIDS.